Point of Care Lipid Test Market Size, Share & Trends Report

Point of Care Lipid Test Market Size, Share & Trends Analysis Report By Instruments (Brand Market Sizing: Roche Reflotron, Roche Cobas b 101, Abaxis Piccolo, Alere Cholestech LDX, Alere Afinion, Samsung LABGEO, PTS CardioChek), By Application (Hyperlipidemia, Hypertriglyceridemia), And Segment Forecasts, 2015 - 2022

  • Published Date: Feb, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-750-6
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 75

Market segmentation

  • Global PoC Lipid Test Market Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
    • Roche Reflotron
    • Roche Cobas b 101
    • Abaxis Piccolo
    • Alere Cholestech LDX
    • Alere Afinion
    • Samsung LABGEO
    • PTS Cardiochek
  • Global PoC Lipid Test Market Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
    • Roche Reflotron
    • Roche Cobas b 101
    • Abaxis Piccolo
    • Alere Cholestech LDX
    • Alere Afinion
    • Samsung LABGEO
    • PTS Cardiochek
  • Global PoC Lipid Test Market Application Outlook (Revenue, USD Million, 2015 - 2022)
    • Hyperlipidemia
    • Hypertriglyceridemia
    • Familial Hypercholesterolemia
    • Hyperlipoproteinemia
    • Tangier disease
    • Others
  • PoC Lipid Test Market Regional Outlook(Revenue, USD Million, 2015 - 2022)
    • North America
      • The U.S.
        • The U.S. Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • The U.S. Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • The U.S. Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
      • Canada
        • Canada Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Canada Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Canada Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
    • Europe
      • The U.K.
        • The U.K. Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • UK Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • The U.K. Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
      • Germany
        • Germany Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Germany Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Germany Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
    • Asia Pacific
      • Japan
        • Japan Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Japan Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Japan Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
      • China
        • China Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • China Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • China Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
      • Australia
        • Australia Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Australia Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Australia Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
    • Latin America
      • Brazil
        • Brazil Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Brazil Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • Brazil Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others
    • Middle East and Africa (MEA)
      • South Africa
        • South Africa Instrument Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • South Africa Consumables Outlook (Revenue, USD Million, Volume, Units 2015 - 2022)
          • Roche Reflotron
          • Roche Cobas b 101
          • Abaxis Piccolo
          • Alere Cholestech LDX
          • Alere Afinion
          • Samsung LABGEO
          • PTS Cardiochek
        • South Africa Application Outlook (Revenue, USD Million, 2015 - 2022)
          • Hyperlipidemia
          • Hypertriglyceridemia
          • Familial Hypercholesterolemia
          • Hyperlipoproteinemia
          • Tangier disease
          • Others

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments 

Quantitative Analysis

  • Market size, estimates, and forecast from 2015 To 2022
  • Revenue estimates for instruments up to 2022
  • Regional market size and forecast for instruments up to 2022
  • Revenue estimates for consumables up to 2022
  • Regional market size and forecast for consumables up to 2022
  • Revenue estimates for application up to 2022
  • Regional market size and forecast for application up to 2022
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.